This content is machine translated Migraine Curbing attacks through proactive measures Migraines can significantly reduce the quality of life of those affected. Early treatment is therefore advisable if the diagnosis is confirmed. Migraine therapy can be divided into three groups: Acute...…
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14–15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 5 min This content is machine translated Treating reflux symptoms Doing one thing but not the other Proton pump inhibitors (PPI) are still the first choice for acute treatment, but long-term use should be avoided. H2 antihistamines also suppress gastric acid secretion. Antacids and alginates can also…
View Post 14 min This content is machine translated Migraine in everyday life Therapy, obstacles and new insights About 12% of the population suffers from migraine. Neurological disease is the second most common reason for living with disability worldwide and the most common reason for people under age… CME-Test
View Post 3 min This content is machine translated Primary headache Problem case migraine: pharmacotherapy put to the test There are many types of headaches. Migraine is certainly one of the most common. Even more so, a form that carries a high burden and far-reaching effects on the quality…
